| |
| |
|
| Insider
Information: |
Brynjelsen Sean |
| Relationship: |
Chief Executive Office... |
| City: |
Schaumburg |
| State: |
IL |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
1,040,000 |
|
|
Indirect Shares
|
24,940 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
1,064,940 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Sagent Pharmaceuticals Inc |
SGNT |
EVP, Business Developm... |
2016-08-29 |
0 |
2016-04-04 |
0 |
Premium* |
|
|
Eton Pharmaceuticals, Inc. |
ETON |
Chief Executive Office... |
2022-09-22 |
1,040,000 |
2022-09-22 |
24,940 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
10 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ETON |
Eton Pharmaceuticals, Inc... |
Chief Executive Officer |
• • – |
2022-09-22 |
4 |
B |
$2.10 |
$21,042 |
D/D |
10,000 |
1,040,000 |
2.81 |
- |
|
| ETON |
Eton Pharmaceuticals, Inc... |
President & CEO |
• • – |
2021-08-20 |
4 |
B |
$4.32 |
$43,200 |
D/D |
10,000 |
1,030,000 |
2.81 |
- |
|
| ETON |
Eton Pharmaceuticals, Inc... |
President & CEO |
• • – |
2021-06-03 |
4 |
B |
$5.96 |
$29,800 |
D/D |
5,000 |
1,030,000 |
2.81 |
- |
|
| ETON |
Eton Pharmaceuticals, Inc... |
President & CEO |
• • – |
2019-08-13 |
4 |
B |
$6.15 |
$30,750 |
D/D |
5,000 |
1,025,000 |
2.81 |
- |
|
| ETON |
Eton Pharmaceuticals, Inc... |
President & CEO |
• • – |
2019-05-21 |
4 |
B |
$7.96 |
$68,431 |
D/D |
8,600 |
1,020,000 |
2.81 |
- |
|
| ETON |
Eton Pharmaceuticals, Inc... |
President & CEO |
• • – |
2019-05-20 |
4 |
B |
$7.78 |
$10,895 |
D/D |
1,400 |
1,011,400 |
2.81 |
- |
|
| ETON |
Eton Pharmaceuticals, Inc... |
President & CEO |
• • – |
2018-11-15 |
4 |
B |
$6.00 |
$60,000 |
D/D |
10,000 |
1,010,000 |
2.81 |
- |
|
| ETON |
Eton Pharmaceuticals, Inc... |
President & CEO |
• • – |
2018-11-15 |
4 |
A |
$0.00 |
$0 |
I/I |
24,940 |
24,940 |
0 |
- |
|
| SGNT |
Sagent Pharmaceuticals In... |
EVP, Business Development |
• – – |
2016-08-29 |
4 |
D |
$21.75 |
$214,107 |
D/D |
(9,844) |
0 |
0 |
- |
|
| SGNT |
Sagent Pharmaceuticals In... |
EVP, Business Development |
• – – |
2016-04-04 |
4 |
A |
$0.00 |
$0 |
D/D |
9,844 |
9,844 |
0 |
- |
|
10 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
